Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Virus Vaccine”

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT02662426
What this trial is testing

Lingdancao Granules in the Treatment of Seasonal Influenza

Who this might be right for
Influenza
The First Affiliated Hospital of Guangzhou Medical University 318
Early research (Phase 1)Study completedNCT03430089
What this trial is testing

Safety of a Single Dose or Two Doses of Shenzhen Quadrivalent Influenza Vaccine

Who this might be right for
InfluenzaFlu
Sanofi Pasteur, a Sanofi Company 101
Testing effectiveness (Phase 2)Study completedNCT05048589
What this trial is testing

Feasibility of Randomizing Danish Citizens Aged 65-79 Years to High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in a Pragmatic Registry-Based Setting

Who this might be right for
Influenza
Tor Biering-Sørensen 12,551
Very early researchStudy completedNCT05401448
What this trial is testing

Non-specific Effects of FLU-MMR Vaccines in Adults

Who this might be right for
COVID-19
Radboud University Medical Center 638
Early research (Phase 1)Looking for participantsNCT07111078
What this trial is testing

Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults

Who this might be right for
Influenza PreventionPandemic Influenza Prevention
National Institute of Allergy and Infectious Diseases (NIAID) 56
Post-approval studies (Phase 4)Study completedNCT04667117
What this trial is testing

Study to Assess Response to Influenza Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 63
Not applicableActive Not RecruitingNCT01866540
What this trial is testing

Immune Response To Intranasal Influenza Vaccination

Who this might be right for
Tonsillitis, Hypertrophy
University of Bergen 300
Testing effectiveness (Phase 2)Study completedNCT00506350
What this trial is testing

Evaluate Reactogenicity & Immunogenicity of an Influenza Pandemic Candidate Vaccine (GSK1562902A) in Primed Adults

Who this might be right for
Influenza
GlaxoSmithKline 350
Post-approval studies (Phase 4)Study completedNCT01262846
What this trial is testing

Improving Immunogenicity of Influenza Vaccine in HIV Infected Individuals

Who this might be right for
HIV Infection
University of Pennsylvania 195
Large-scale testing (Phase 3)Study completedNCT01218646
What this trial is testing

Study of Quadrivalent Influenza Vaccine Among Adults

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 739
Large-scale testing (Phase 3)Study completedNCT01199861
What this trial is testing

Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS)

Who this might be right for
Relapsing Multiple Sclerosis
Novartis 138
Early research (Phase 1)Study completedNCT01428479
What this trial is testing

Phase1 Study of GR121167, Single and Multiple Dose Study in Healthy Japanese Males

Who this might be right for
Influenza, Human
GlaxoSmithKline 18
Large-scale testing (Phase 3)Study completedNCT00001127
What this trial is testing

Study of a Flu Vaccine in Children

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 15,000
Testing effectiveness (Phase 2)Study completedNCT01938352
What this trial is testing

Evaluation of the Protective Efficacy and Safety of CR8020 in an Influenza Challenge

Who this might be right for
Influenza
Crucell Holland BV 22
Large-scale testing (Phase 3)Study completedNCT00959049
What this trial is testing

Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine in a Pediatric Population

Who this might be right for
Influenza
Seqirus 1,474
Post-approval studies (Phase 4)Study completedNCT02748785
What this trial is testing

MTX Discontinuation and Vaccine Response

Who this might be right for
Arthritis, Rheumatoid
Seoul National University Hospital 277
Large-scale testing (Phase 3)UnknownNCT05494047
What this trial is testing

Phase Ⅲ, Clinical Trial to Compare an Inactivated Quadrivalent Influenza Vaccine and a Licensed Vaccine in Chile

Who this might be right for
InfluenzaVaccines
Pontificia Universidad Catolica de Chile 1,600
Not applicableStudy completedNCT01254955
What this trial is testing

Antibody Production Following H1N1 Influenza Vaccination in Organ Transplant Patients

Who this might be right for
Organ Transplantation
Sahlgrenska University Hospital
Testing effectiveness (Phase 2)Study completedNCT00479648
What this trial is testing

Immunogenicity, Safety and Tolerability of CSL412 in Elderly Participants

Who this might be right for
Influenza
Seqirus 612
Large-scale testing (Phase 3)Study completedNCT00760617
What this trial is testing

Evaluation of Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Years and Older

Who this might be right for
Influenza
GlaxoSmithKline 526
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation